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Y2Y4 receptor double knockout protects against obesity due 
to a high-fat diet or Y1 receptor deficiency in mice 
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Neuropeptide Y receptors are critical regulators of energy homeostasis, but the functional 
interactions and relative contributions of Y receptors and the environment in this process are 
unknown. We measured the effects of an ad libitum diet of normal or high-fat food on energy 
balance in mice with single, double, or triple deficiencies of Y1, Y2, or Y4 receptors. Whereas 
wild-type mice developed diet-induced obesity, Y2Y4 double knockouts did not. In contrast, 
Y1 knockout or Y1Y2 or Y1Y4 receptor double knockout mice developed an exacerbated diet-
induced obesity syndrome. Remarkably, the antiobesity effect of Y2Y4 deficiency was 
stronger than the obesogenic effect of Y1 deficiency, since Y1Y2Y4 triple knockouts did not 
develop obesity on the high-fat diet. Resistance to diet-induced obesity in Y2Y4 knockouts 
was associated with reduced food intake and improved glucose tolerance in the absence of 
changes in total physical activity. Fecal concentration of free fatty acids was significantly 
increased in Y2Y4 knockouts in association with a significantly reduced bile acid pool and 
marked alterations in intestinal morphology. In addition, hypothalamic proopiomelanocortin 
expression was decreased in diet-induced obesity (in both wild-type and Y1 receptor 
knockout mice) but not in obesity-resistant Y2Y4 receptor knockout mice fed a high-fat diet. 
Therefore, deletion of Y2 and Y4 receptors synergistically protects against diet-induced 
obesity, at least partially via changes in food intake and hypothalamic proopiomelanocortin 
expression. 
 
---------------------------------------------------------------------------------------------------------------------------- 
 
Members of the Y receptor family, notably Y1, Y2, Y4, and Y5 receptors, are implicated in 
energy homeostasis and the development of obesity and insulin resistance. These receptors 
are activated by three endogenous ligands: neuropeptide Y, the gut-derived hormones 
peptide YY, and pancreatic polypeptide. Recently, there has been renewed speculation that 
ligands for Y receptors, such as peptide YY3-36 and pancreatic polypeptide, may be of 
benefit for the treatment of obesity (1). 
 There is considerable conflict in the literature about the role of Y receptors in the 
regulation of body weight. For instance, pharmacological studies suggested that Y1 receptors 
contribute to hyperphagia induced by increased hypothalamic neuropeptide Y secretion ( 2). 
Fasting-induced refeeding is reduced in Y1 knockout mice ( 3). Moreover, food intake and 
body weight of genetically obese ob/ob mice, in which hypothalamic neuropeptide Y-ergic 
activity is chronically increased, are significantly reduced by Y1 knockout ( 4). In contrast, Y1 
knockouts develop significant increases in body weight, fat mass, and insulinemia in the 
absence of hyperphagia (3,5). 
 Similar controversies prevail regarding the role of Y2 receptors in energy 
homeostasis. Hypothalamus-specific or germ-line deletion of Y2 receptors resulted in 
significant reductions in the body weight of lean mice (6) and significant reductions in 
adiposity or body weight and the type 2 diabetic syndrome of ob/ob mice in the absence of 
reductions in food intake (7,8). In contrast, another germline Y2 receptor knockout model was 
shown to develop increased body weight, fat deposition, and hyperphagia (9). Furthermore, 
intrahypothalamic administration of the Y2 agonist neuropeptide Y[13-36] to rats significantly 
decreased food intake (10). Moreover, circulating peptide YY from the gut and its truncated 
form peptide YY3-36 (a preferential Y2 agonist) have been shown to reduce food intake, 
adiposity, and/or body weight after short- or long-term administration to lean or obese rodents 
or humans (1,11,12). 
 Recent work suggests that pancreatic polypeptide, a preferential Y4 receptor agonist 
secreted by the F cells of the islets of Langerhans, regulates energy homeostasis. 
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Intravenous or intraperitoneal administration of pancreatic polypeptide to mice increases 
metabolic rate (13) and decreases hyperglycemia, basal or glucose-induced 
hyperinsulinemia, insulin resistance, and hyperlipidemia in ob/ob mice, culminating in 
decreases in adiposity and body weight (13,14). Pancreatic polypeptide transgenic mice, 
which have a 20-fold increase in plasma pancreatic polypeptide levels, have reduced food 
intake, body weight, and fat mass as well as reduced glucose-induced insulin secretion and 
gastric emptying when compared with control mice (15). However, other findings do not 
support a role of Y4 receptors in energy homeostasis. Y4 receptor knockout had no effect on 
the hyperphagia, obesity, or type 2 diabetic phenotype of ob/ob mice (16). 
 These conflicting data make it difficult to define the true physiological and 
pathophysiological role of Y receptors in energy homeostasis and obesity. Moreover, it is 
difficult to know whether potential obesity treatments targeted to Y receptors should act as 
agonists or antagonists. Part of this conflict can be explained by the fact that Y receptors 
mediate their physiological effects via complex synergistic and redundant interactions. For 
instance, knockout of individual Y receptors alters ligand-binding patterns of the remaining Y 
receptors (17). In addition, ligands for Y receptors are renowned for their lack of specificity for 
individual receptor types. 
 To circumvent some of these complications of Y receptor biology, we made a 
systematic study of energy balance in mice with single, double, or triple knockout of Y1, Y2, 
or Y4 receptors, both under chow-fed conditions and in diet-induced obesity. In this way, we 
were able to clarify the interactions among these receptor types in regulating energy balance 
(including body weight, food intake, physical activity, thermogenesis, glucose tolerance, 
intestinal lipid absorption, intestinal morphology, and hypothalamic expression of 
neuropeptide Y and proopiomelanocortin) and to elucidate their roles in the development of 
diet-induced obesity. Y5 receptor knockouts were not investigated in this study because the 
Y5 and Y1 receptors are localized only 20 kb apart on the same chromosome, and it is 
therefore not plausible to obtain Y1Y5 receptor double knockout mice by cross-breeding. 
 
RESEARCH DESIGN AND METHODS 
Generation of the Y1, Y2, and Y4 knockout mice were previously published (6,16,18). Male 
double or triple knockout mice were obtained by crossing Y1, Y2, or Y4 knockout mice, 
respectively. All mice were on a mixed C57BL/6129/SvJ background. All research and animal 
care procedures were approved by the Garvan Institute/St. Vincent's Hospital Animal 
Experimentation Ethics Committee and were in agreement with the Australian Code of 
Practice for the Care and Use of Animals for Scientific Purpose. Mice were housed under 
conditions of controlled temperature (22°C) and illumination (12-h light cycle, lights on at 
0700). Haft of the mice of each genotype were fed a normal chow diet ad libitum (6% calories 
from fat, 21% calories from protein, 71% calories from carbohydrate, and 2.6 kcal/g; Gordon's 
Speciality Stock Feeds, Yanderra, NSW, Australia). The other haft was fed ad libitum with a 
high-fat diet supplemented with fat and sucrose (46% calories from fat, 21% calories from 
protein, 33% calories from carbohydrate, and 4.72 kcal/g) from 8 weeks of age onwards. The 
diet was based on the composition of rodent diet catalog no. D12451 (Research Diets, New 
Brunswick, NJ), with the exception that safflower oil and copha were used in place of soybean 
oil and lard. Twenty-four-hour food intake was estimated twice a week for 4 weeks from 13 to 
16 weeks of age by the average amount of food removed from the food hopper. In a subset of 
animals, the actual proportion of food that was consumed was calculated by subtracting the 
weight of the food spilt in the cage from the weight of food removed from the hopper. Body 
temperature was determined at 14-16 weeks of age (BAT-10 multipurpose thermometer; 
Physitemp Instruments, Clifton, NJ). 
Determination of physical activity. Distance traveled in the open field test was determined 
as previously described (19). Total cage activity was recorded using a passive infrared 
detector (Conrad Electronics, Hanover, Germany) on top of the cage lid of single-housed 
animals. The signals of the passive infrared detectors were detected by an I/O interface card 
(PIO48 II; Conrad Electronics) and stored using custom-made software. A mean activity per 
day was calculated by averaging corresponding 30-min intervals of 7 consecutive days. 
Glucose tolerance tests and tissue collection. At 16 weeks of age, animals were fasted 
overnight and then administered an intraperitoneal injection of D-glucose (60 mg/mouse).  
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Glucose levels were determined in tail blood samples, with glucose test strips (Accu-Check 
Advantage II Glucose Test Strips; Roche Diagnostics Australia, Castle Hill, NSW, Australia). 
At 3-8 days after the glucose tolerance test, food was removed from cage hoppers at 0900, 
and animals were killed 4-7 h later by cervical dislocation followed by cardiac puncture for 
serum collection. Brains were immediately removed and frozen on dry ice. The interscapular 
brown adipose tissue was removed, weighed, and stored frozen until analysis for uncoupling 
protein-1 mRNA levels (20). Epididymal white adipose tissue (WATe) depots were dissected 
and weighed. The small intestine of some mice was removed and prepared for histology as 
described below. In separate groups of mice, the small intestine was flushed with isotonic 
saline, blotted on paper towels, and weighed. In other mice, the liver, gallbladder, small 
intestine and contents were removed, weighed, and stored at --80°C until analysis of total bile 
acid pool (21). 
Analysis of fecal lipids and bile acids. Fecal samples were dried to a constant weight at 
90°C. Some fecal samples were used for extraction of total lipids (22). Lipids were 
resuspended in pure chloroform and separated by TLC (thin-layer chromatography) on 
Whatman Silica Gel K6 glass TLC plates (Whatman, Maidstone, England) in hexane:diethyl 
ether:acetic acid, 80:20:1. Standards were triolein (50 µg), dipalmitine (75 µg), and palmitine 
(125 µg) (Sigma, St. Louis, MO). Fractious corresponding to triglycerides, diglycerides, 
monoglycerides, and free fatty acids were scraped from the plate for assay of triacylglycerol 
(23). The free fatty acid fraction was resuspended in chloroform and assayed for free fatty 
acids with a colorimetric assay kit (WAKO, Saitama, Japan). Other samples of feces were 
used for determination of fecal bile acid concentration (21). 
Analysis of intestinal morphology. One-centimeter pieces of small intestine were taken 
from the following three locations: duodenum, 3 cm distal from the stomach-duodenal 
junction; jejunum, at the midpoint of the small intestine; and ileum, 3 cm proximal from the 
ileocaecal junction. Intestinal pieces were fixed for 16-18 h in Bouin's solution (Sigma), 
embedded in paraffin, sectioned at 7 µm, mounted on charged slides (SuperFrost Plus; 
MenzelGlaser, Braunschweig, Germany), and stained with periodic acid Schiff. Villus length 
(from base of the crypt to tip of the villus) was measured in at least 15 villi from three mice in 
each group, using a light microscope (Axiophot; Zeiss, Oberkochen, Germany) connected to 
a Leica camera and Leica Image Manager software (Leica, Heerbrugg, Switzerland). The 
number of goblet cells per villus (excluding crypts) were counted in at least 15 villi from five 
mice in each group. All analyses were done by investigators unaware of genotype. 
Neurochemical analyses. Coronal brain slices (20 µm) at the level of the hypothalamic 
arcuate nucleus were hybridized using DNA oligonucleotides complementary to mouse 
neuropeptide Y and proopiomelanocortin (POMC) (7). 
Serum analyses. Serum hormone levels were determined with commercial 
radioimmunoassay kits from Linco Research (St. Louis, MO) (leptin and insulin), ICN 
Biomedicals (Costa Mesa, CA) (corticosterone, free T4, and testosterone), and Bioclone 
Australia (Marrickville, Australia) (IGF-1). Basal serum glucose levels were determined with a 
glucose oxidase kit (Trace Scientific, Melbourne, Australia). 
Statistical analysis. All data are expressed as means ± SE. Differences among groups of 
mice were assessed by ANOVA or repeated-measures ANOVA, followed by Fisher's post hoc 
comparisons, if appropriate (StatView version 4.51; Abacus Concepts, Berkeley, CA). 
Statistical significance was defined as P < 0.05. 
 
 
RESULTS 
Effects of Y receptor deficiency on diet-induced obesity. The body weights of mice at 8 
weeks of age (before the introduction of the high-fat diet) were not significantly different from 
each other, except for Y1Y2Y4 triple knockout mice, which were lighter (wild-type, 23.7 ± 0.3 
g; Y1, 22.8 ± 0.6 g; Y1Y2, 24.0 ± 0.4 g; Y1Y4, 24.2 ± 0.4 g; Y2, 24.5 ± 0.6 g; Y4, 24.4 ± 0.3 g; 
Y2Y4, 24.8 ± 0.4 g; and Y1Y2Y4, 22.1 ± 0.5 g, P < 0.05 vs. wild-type, n = at least 11 mice per 
genotype). Figure 1A, ⇔ shows that under chow-fed conditions, body weight gain from 8 
weeks until 16 weeks of age was similar in all groups of mice, except for Y1 knockout and 
Y1Y4 double knockout mice. The absolute and relative weights of the WATe depot and serum  
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leptin levels were similar in all groups of mice under chow-fed conditions, except for Y2Y4 
double and Y1Y2Y4 triple knockout mice, which showed significant decreases (Fig. 1B and C, 
Fig. 2A, ⇔). Under chow-fed conditions, serum insulin levels were significantly increased over 
wild-type values in Y1 and Y1Y4 double knockout mice, and significantly decreased relative to 
wild-type in Y2Y4 double knockouts (Fig. 2B, ⇔). In chow-fed animals, there were no 
significant differences among groups with respect to serum levels of corticosterone or free T4 
(Fig. 1C and D), glucose, testosterone, or IGF-1 (data not shown). When fed ad libitum for 8 
weeks on the high-fat diet, wild-type mice developed a distinct obesity syndrome 
characterized by increased body weight gain (Fig. 1A), increased WATe weight (Fig. 1B and 
C), and increases in serum leptin, insulin, and corticosterone levels (Fig. 2A-C), with a 
tendency to decreased free T4 levels (Fig. 2D). Y1 receptor deficiency, either alone or in 
combination with Y2 or Y4 receptor deficiency (i.e., Y1, Y1Y2, and Y1Y4 receptor knockout 
mice), exacerbated this diet-induced obesity syndrome (Figs. 1A-C and 2B). Y1, Y1Y2, and 
Y1Y4 receptor knockout mice also developed hyperleptinemia, hypercorticosteronemia, and a 
tendency to decreased free T4 levels after high-fat feeding, but these responses were not 
significantly different from wild-type animals (Fig. 2A,C,D). In contrast to the exacerbating 
effect of Y1 deficiency on diet-induced obesity, Y2 or Y4 deletion (in Y2, Y4, Y2Y4 double,  
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and Y1Y2Y4 triple knockout mice) conferred protection against diet-induced obesity (Figs. 1 
and 2). However, similar to wild-type mice, Y2, Y2Y4 double, and Y1Y2Y4 triple knockout 
mice showed marked decreases in serum free T4 levels in response to high-fat feeding (Fig. 
2D). 
 
 
Effects of Y receptor deficiency on feeding behavior and food intake. As shown by the 
open columns in Fig. 3, Y1Y4, Y4, Y2Y4 double, and Y1Y2Y4 triple knockout mice removed 
significantly more normal chow from the hopper everyday compared with wild-type mice. 
When fed the high-fat diet, Y1Y4, Y2Y4 double, and Y1Y2Y4 triple knockout mice removed 
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significantly more high-fat diet from the cage hopper than wild-type controls (Fig. 3, ∎). Y2Y4 
double knockout mice spilled significantly more of the food taken from the cage hopper than 
wild-type mice, and the amount of chow or high-fat food actually consumed was significantly 
less than that consumed by wild-types (Fig. 4). There was no significant effect of diet or 
genotype on water intake (data not shown). Because double deletion of Y2 and Y4 receptors 
conferred resistance against diet-induced obesity (even in combination with Y1 receptor 
deficiency), we focused our attention from here onwards on the Y2Y4 knockouts. 
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No effect of Y2Y4 receptor double knockout on physical activity or thermogenesis. In 
the open field test, there was no significant difference between Y2Y4 double knockout mice 
and wild-type controls with respect to total distance traveled (6,960 ± 510 vs. 5,830 ± 240 
cm/30 min, respectively; n = at least 4 mice per group). Moreover, there was no significant 
difference between double knockout and wild-type mice with respect to total physical activity 
in the home cage (data not shown). 
 As an index of nonactivity thermogenic capacity, we measured expression of 
uncoupling protein-1 mRNA in brown adipose tissue ( 24) and rectal temperature in Y2Y4 
double knockout and wild-type mice. There was no significant difference between groups with 
respect to uncoupling protein-1 mRNA levels in brown adipose tissue, standardized to 
glyceraldehyde-3-phosphate dehydrogenase mRNA levels and expressed as a percent of 
wild-type values (107.3 ± 6.7 vs. 100.0 ± 7.4% in Y2Y4 double knockout and wild-type mice, 
respectively; n = 5 mice per group). Moreover, rectal temperature of chow- or fat-fed Y2Y4 
receptor double knockout mice was not significantly different from that of wild-type mice fed 
on the same diet (data not shown). 
Enhanced glucose tolerance in Y2Y4 receptor double knockout mice. There was no 
significant difference among groups with respect to peak glycemia following intraperitoneal 
glucose injection. However, in Y2, Y2Y4 double, and Y1Y2Y4 triple knockout mice, there was 
a significant reduction in serum glucose levels at 60 and 90 min postinjection compared with 
wild-type mice (Fig. 5). All other groups of mice (Y1, Y1Y2 double, Y1Y4 double, and Y4 
knockout mice) showed glucose clearance curves indistinguishable from wild-type mice (Fig. 
5). 
Decreased intestinal lipid absorption in Y2Y4 receptor double knockout mice. Fig. 6 
shows the concentration of triglycerides, diglycerides, and free fatty acids in feces from wild-
type and Y2Y4 receptor double knockout mice, either under chow-fed (Fig. 6A) or high-fat-fed 
(Fig. 6B) conditions. In both groups of mice, free fatty acids were the most abundant fecal 
lipid species, and undigested or partially digested lipids (triglycerides and diglycerides) were 
6- to 30-fold less abundant. Monoglycerides were not detectable in the fecal samples 
investigated. These findings indicate that triglyceride digestion to free fatty acids proceeds 
efficiently in both wild-type and Y2Y4 receptor double knockout mice. However, absorption of 
digested lipids may be impaired in Y2Y4 double knockout mice, since the fecal concentration 
of free fatty acids was increased in knockout versus wild-type mice, significantly so during 
high-fat feeding (Fig. 6B). Dally fecal output (dried weight) from Y2Y4 double knockout mice 
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on a chow diet was significantly less than that of wild-type controls (0.64 ± 0.12 vs. 1.23 ± 
0.04 g ⋅ mouse-1 ⋅ day-1, n = 3-4 cages of 2-4 mice per group). However, there was no 
significant difference in dally fecal output between knockout and wild-type mice on the high-fat 
diet (0.22 ± 0.02 vs. 0.25 ± 0.04 g ⋅ mouse-1 ⋅ day-1 in wild-types, n 3-4 cages of 2-4 mice per 
group). 
 
 
Reduced bile pool and differences in intestinal morphology in Y2Y4 receptor double 
knockout mice. We determined the total bile pool because intestinal lipid absorption is 
dependent on bile production. The total bile pool of Y2Y4 knockouts was significantly reduced 
compared with wild-type mice (20.0 ± 3.6 vs. 41.0 ± 3.0 μmol total bile, respectively; and 88 ± 
17 vs. 142 ± 10 µmol/100 g body wt, respectively; means ± SE of 12-13 mice per group, P < 
0.01). Fecal total bile acid concentration was similar in Y2Y4 knockout and wild-type mice (33 
± 9 vs. 34 ± 2 µmol/g dried feces, respectively, means ± SE of at least three mice per group). 
Since dally fecal output was reduced by 50% in Y2Y4 versus wild-type mice, total bile acid 
output of Y2Y4 knockouts was therefore half that of wild-type counterparts, in keeping with 
the smaller total bile acid pool size. 
 Although there was no significant difference between wild-type and knockout mice 
with regards to either weight (1.1 ± 0.05 vs. 1.1 ± 0.05 g, respectively; means ± SE of 22-24 
mice per group) or length (39.4 ± 0.8 vs. 37.6 ± 0.6 cm, respectively; means ± SE of 25-27 
mice per group) of the small intestine, the average length of small intestinal villi was 
significantly decreased in the duodenum of Y2Y4 double knockout versus wild-type mice (431 
± 2 vs. 525 ± 6 µm, respectively, n = 3 mice per genotype, P < 0.05) (Fig. 7A and B). This 
difference in villus length was not observed in the jejunum (295 ± 16 vs. 287 ± 6 µm; Y2Y4 
and wild-type mice, respectively, n = 3 mice per genotype) or ileum (204 ± 24 vs. 184 ± 15 µm 
in Y2Y4 and wild-type mice, respectively, n = 3 mice per genotype). Y2Y4 receptor double 
knockout mice had an increase over wild-type mice in the number of goblet cells in the 
duodenum (23.7 ± 1.7 vs. 20.6 ± 1.0 goblet cells per villus in wild-type mice, n = 5 mice per 
group, NS), the jejunum (21.6 ± 1.1 vs. 18.0 ± 0.6 goblet cells per villus in wild-type mice, n = 
5 mice per group, P < 0.05), and the ileum (23.1 ± 1.4 vs. 18.2 ± 0.6 goblet cells per villus in 
wild-type mice, n = 5 mice per group, P < 0.05). Representative villi from the ileum of wild-
type and Y2Y4 receptor knockout mice are shown in Fig. 7C and D. 
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Altered hypothalamic expression of neuropeptide Y and POMC in Y receptor knockout 
mice. In wild-type mice, the high-fat diet resulted in significant decreases in neuropeptide Y 
and POMC mRNA levels in the arcuate nucleus (Table 1). Increased weight gain in both 
chow-fed and high-fat--fed Y1 receptor knockout mice, compared with wild-types, was 
associated with decreased neuropeptide Y and POMC mRNA levels compared with wild-type 
values (Table 1). In addition, in Y1 receptor knockout mice, diet-induced obesity was 
associated with decreased neuropeptide Y and POMC mRNA levels compared with chow-fed 
mice (Table 1). In contrast, in Y2Y4 receptor knockout mice, neuropeptide Y and POMC 
mRNA levels were not significantly decreased following ingestion of a high-fat diet compared 
with chow-fed double knockouts. Rather, neuropeptide Y and POMC mRNA levels were 
increased in Y2Y4 receptor knockout mice compared with wild-type mice fed the same diet 
(Table 1). 
 
 
 
 
DISCUSSION 
These data demonstrate that ablation of Y2 and Y4 receptors protects against diet-induced 
obesity, probably via reduced food intake. In contrast, deletion of Y1 receptors significantly 
exacerbates diet-induced obesity. Moreover, the antiobesity effect of double Y2 and Y4 
receptor deficiency overrides the obesogenic effect of Y1 receptor deficiency and a high-fat 
diet (as seen in Y1Y2Y4 triple knockout mice). These observations provide evidence that the 
molecular system that regulates energy homeostasis, including the Y receptor system, has 
less redundancy and capacity for compensation to favor positive over negative energy 
balance than previously thought. 
 We recently showed that Y2 and Y4 receptor knockout synergistically increases bone 
volume in conjunction with a significant increase in bone formation rate (25). It is therefore 
conceivable that in addition to decreased food intake, this threefold increase in bone volume 
could contribute to the lean phenotype observed in Y2Y4 receptor double knockout mice. 
 The current work suggests that Y2Y4 receptor double deficiency decreases 
absorption of fat from the digestive tract. This change was not associated with any decrease 
in efficiency of triglyceride digestion to free fatty acids. The reduced intestinal fat absorption in 
Y2Y4 receptor knockout mice is likely to be mediated, at least in part, by the reduced total bile 
pool observed in these animals. Indeed, fat absorption and energy extraction from food is 
positively correlated with the concentration of functional bile acids (26,27). It is unlikely 
however that decreased intestinal lipid absorption contributes to the lean phenotype of Y2Y4 
receptor knockout mice, since the calorie content of the extra free fatty acids excreted in the 
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feces of these mice represents <1% their total dally calorie intake. Previous work has shown 
that both peptide YY and pancreatic polypeptide inhibit gallbladder emptying (28) or 
gallbladder bile output in pigs and/or humans ( 28, 29), presumably via interactions with Y 
receptors in the dorsovagal complex of the brain stem and subsequent vagal-dependent 
pathways (28,30). The current work extends these data to show the unambiguous 
involvement of Y2 and Y4 receptors in the regulation of total bile pool. 
 Reduced intestinal absorption of lipids in Y2Y4 receptor double knockout mice may 
be influenced by the observed decrease in villus length of the duodenum. It is also possible 
that the increased number of goblet cells observed in the small intestine of Y2Y4 receptor 
double knockout mice may have led to increased production of intestinal mucus, which could 
accelerate intestinal transit and impair absorption of nutrients (31). 
 In contrast to the protective effects of Y2 and Y4 receptor deficiency against diet-
induced obesity, animals deficient in Y1 receptors had a tendency for increased adiposity 
under chow-fed conditions and had an exacerbated obesity syndrome in response to the 
high-fat diet. This was observed in single Y1 receptor knockout animals as well as in Y1Y2 
and Y1Y4 double knockout animals. In Y1Y2Y4 receptor triple knockout animals however, the 
antiobesity effect of Y2 and Y4 receptor deficiency predominated over the obesogenic effect 
of Y1 deficiency and a high-fat diet. It is likely that hormonal and metabolic alterations, notably 
hyperinsulinemia, contribute to the increased propensity for obesity in Y1, Y1Y2, and Y1Y4 
receptor knockout mice. When injected peripherally or when administered to pancreatic tissue 
in vitro, neuropeptide Y decreases insulin secretion (32,33), probably via direct interaction 
with the Y1 receptors expressed on pancreatic β-cells (34,35). It is likely that the lack of Y1 
receptors on pancreatic islet tissue contributed to the increased basal serum insulin levels of 
Y1, Y1Y2, and Y1Y4 receptor knockout mice, with hyperinsulinemia subsequently contributing 
to increased adiposity (36). Indeed, we have shown that glucose-induced serum insulin levels 
are increased in Y1 knockout compared with wild-type mice (A.S., N.J.L., K.S., R.E., and 
H.H., unpublished data). Other groups have also reported that germline Y1 receptor knockout 
induces obesity and basal hyperinsulinemia ( 3, 5, 37) and that hyperinsulinemia is likely to 
be a key etiological feature in the obese phenotype of these mice (37). 
 High-fat feeding resulted in decreased expression of neuropeptide Y in the arcuate 
nucleus of wild-type mice and Y1 receptor knockout mice, possibly as an adaptive response 
to inhibit further weight gain. This is most likely mediated via increased circulating 
concentrations of leptin and the gut peptide peptide YY3-36, release of which is strongly 
increased by dietary fat ( 38, 39), subsequently acting on leptin or Y2 receptors in the arcuate 
nucleus to reduce neuropeptide Y expression levels and thereby reducing feeding (1,40,41). 
Expression of POMC in the arcuate nucleus of wild-type and Y1 receptor knockout mice fed a 
high-fat diet was also reduced, a change that may contribute to the diet-induced obesity 
observed in these mice by decreasing secretion of α-melanocyte stimulating hormone. 
Consistent with this hypothesis, rodent obesity models of genetic (42,43) or dietary (44) origin 
exhibit decreased expression of POMC in the arcuate nucleus. It was of interest that the 
decreases in hypothalamic expression of neuropeptide Y and POMC induced by the high-fat 
diet were absent in obesity-resistant Y2Y4 receptor knockout mice and were exacerbated in 
obesityprone Y1 receptor knockout mice. These findings suggest a possible causative role of 
changes in POMC signaling in the development or resistance to diet-induced obesity in wild-
type, Y1 knockout, and Y2Y4 receptor double knockout mice. 
 We recently demonstrated that single, double, or triple deletion of Y1, Y2, or Y4 
receptors alters the expression or binding patterns of the remaining Y receptors in the brain 
(17). However, the major changes observed are located in areas not likely to participate in the 
regulation of energy homeostasis, notably the hippocampus. Therefore, it is unlikely that the 
changes in energy homeostasis observed in our panel of Y receptor knockout mice were due 
to compensatory changes in other Y receptors remaining in the hypothalamus. 
 In conclusion, these data demonstrate that Y2 and Y4 receptors are necessary for 
diet-induced obesity, at least in part via effects on food intake and hypothalamic POMC 
expression. In contrast, Y1 receptors inhibit diet-induced obesity, probably via direct inhibition 
of insulin secretion from pancreatic β-cells. These data clearly indicate the possibility that 
simultaneously inhibiting and/or activating different Y receptors with a combination of Y 
receptor antagonists and agonists could provide new treatments to improve the efficiency of 
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lifestyle interventions for obesity. 
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